Investment Analysts' New Coverage for February 25th (AMPE, A

Investment Analysts’ new coverage for Sunday, February 25th: StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE). The firm issued a sell rating on the stock. StockNews.com assumed coverage on shares of Applied DNA Sciences (NASDAQ:APDN). The firm issued a hold rating on the stock. StockNews.com initiated coverage on shares of BlackRock Capital Investment (NASDAQ:BKCC). […]

Related Keywords

South Carolina , United States , , Pieris Pharmaceuticals , Nustar Energy , Nasdaq , Codorus Valley Bancorp , Callon Petroleum , Ampio Pharmaceuticals , Ampio Pharmaceuticals Inc , News Ratings For Ampio Pharmaceuticals Inc Daily , Creative Media Community Trust Co , Investment Analyst , Blackrock Capital Investment , Bridgeline Digital , Broadway Financial , Creative Media , Community Trust , Cedar Fair , Gold Resource , Lightpath Technologies , Moleculin Biotech , Navidea Biopharmaceuticals , Pioneer Natural Resources , Arcadia Biosciences , Six Flags Entertainment , Sorrento Therapeutics , United States Steel , Xcel Brands , Ampio Pharmaceuticals Inc Daily ,